Asthma Therapy
Research add new data to asthma therapy body of knowledge
Published in Clinical Trials Week, November 14th, 2005
Study 1: Inhaler choice does not significantly affect budesonide efficacy in asthma patients.
"Bronchial hyperresponsiveness to adenosine monophosphate, an indirect measure of airway inflammation, is a sensitive marker of inhaled corticosteroid efficacy," scientists in Scotland noted. In a "double-masked, dose-response crossover study," they compared the "relative therapeutic efficacy of budesonide delivered via Clickhaler and Turbuhaler dry powder inhalers in patients with mild-to-moderate persistent asthma."
"Twenty-seven patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2005-11-14)
More Articles from Clinical Trials Week
- Chronic Daily Headache
High-dose Botox shows promise as prophylactic treatment - Clinical Trials
Study shows interferon treatment delays MS onset in patients showing clinical signs - Crohn Disease
Phase II Trial results for treatment of Crohn Disease with Cimzia are positive - Drug Development
Data being analyzed in phase II CoFactor trial in patients with metastatic colorectal cancer - Erectile Dysfunction
Tadalafil effective during thiazide diuretic hypertension therapy - Adverse Drug Reaction
Tysabri safety evaluation complete; no new confirmed cases of PML - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
